This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • A Study of Relatlimab Plus Nivolumab in Combinatio...
Clinical trial

A Study of Relatlimab Plus Nivolumab in Combination With Chemotherapy vs. Nivolumab in Combination With Chemotherapy as First Line Treatment for Participants With Stage IV or Recurrent Non-small Cell Lung Cancer (NSCLC)

Read time: 1 mins
Last updated:23rd May 2021
Status: Recruiting
Identifier: NCT04623775
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest